Edoxaban Dosing Regimens Evaluated for AF-Related Stroke
The comprehensive net clinical outcomes of low- and high-dose edoxaban was evaluated for stroke in atrial fibrillation.
The comprehensive net clinical outcomes of low- and high-dose edoxaban was evaluated for stroke in atrial fibrillation.
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
The BBV152 vaccine, produced by Bharat Biotech International, was a whole-virion -propiolactone-inactivated SARS-CoV-2 vaccine formulated by Algel-alum or Algel-IMDG adjuvants.
Study authors assessed the economic trade-offs of expanding and accelerating testing for SARS-CoV-2 across the United States in different transmission scenarios.
Researchers compared a potent antiplatelet inhibition strategy with a less potent inhibition treatment plan in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
Study authors examined the effect of high-dose zinc and/or ascorbic acid on the severity or reduction of SARS-CoV-2 duration compared with the standard of care.
Bouts of intense exercise can lead to cardiorespiratory fitness and decreased risk for cardiovascular disease in patients with type 2 diabetes.
Study authors analyzed data from Israel’s largest health care organization to evaluate the effectiveness of Pfizer’s COVID-19 mRNA vaccine, BNT162b2, in a real world setting.
Study authors assessed the diagnostic accuracy of saliva NAAT for COVID-19 due to the increased resources, such as trained personnel, required for nasopharyngeal swab NAAT.